|
QianRen Biology 2015
干细胞生物技术专利信息情报初步分析
|
Abstract:
[1] | Morales, E.E. and Wingert, R.A. (2014) Renal Stem Cell Reprogramming: Prospects in Regenerative Medicine. World Journal of Stem Cells, 6, 458-466. http://dx.doi.org/10.4252/wjsc.v6.i4.458 |
[2] | Ishii, T. and Eto, K. (2014) Fetal Stem Cell Transplantation: Past, Present, and Future. World Journal of Stem Cells, 6, 404-420. http://dx.doi.org/10.4252/wjsc.v6.i4.404 |
[3] | Noiseux, N., Marquis-Gravel, G., Mansour, S., Shahzad, U., Stewart, D.J. and Yau, T.M. (2014) The Current State of Stem Cell Therapeutics: Canadian Approaches in the International Context. Canadian Journal of Cardiology, 30, 1361-1369. http://dx.doi.org/10.1016/j.cjca.2014.04.031 |
[4] | Xiao, L., Saiki, C. and Ide, R. (2014) Stem Cell Therapy for Central Nerve System Injuries: Glial Cells Hold the Key. Neural Regeneration Research, 9, 1253-1260. http://dx.doi.org/10.4103/1673-5374.137570 |
[5] | Bensinger, W. (2014) Allogeneic Stem Cell Transplantation for Multiple Myeloma. Hematology/Oncology Clinics of North America, 28, 891-902. http://dx.doi.org/10.1016/j.hoc.2014.06.001 |
[6] | Matar, A.A. and Chong, J.J. (2014) Stem Cell Therapy for Cardiac Dysfunction. Springerplus, 3, 440.
http://dx.doi.org/10.1186/2193-1801-3-440 |
[7] | 闫舫, 王韫芳, 刘大庆, 袁红丰, 张鹏, 管利东, 师伟, 姚海雷, 杨印祥, 裴雪涛. 干细胞专利现状研究[J]. 中华医学科研管理杂志, 2006, 19(4): 197-200, 242. |
[8] | Wang, S.J. (2011) The Stem Cell Patent Landscape as Relevant to Cancer Vaccines. Human Vaccines, 7, 1100-1108.
http://dx.doi.org/10.4161/hv.7.10.17022 |
[9] | Quattrocelli, M., Thorrez, L. and Sampaolesi, M. (2013) Pluripotent Stem Cell Derivation and Differentiation toward Cardiac Muscle: Novel Techniques and Advances in Patent Literature. Recent Patents on Drug Delivery and Formulation, 7, 18-28. http://dx.doi.org/10.2174/187221113804805883 |